Associate Director, Financial Planning & Analysis
Fogpharma
Rol hakkında
About Parabilis Medicines
Parabilis Medicines is a clinical-stage biopharmaceutical company dedicated to creating extraordinary medicines for patients with serious diseases by unlocking biologically important targets long considered undruggable. The company has pioneered a new class of alpha-helical peptides – Helicons™ – capable of modulating intracellular proteins that have historically been beyond the reach of conventional medicines. The company’s lead investigational medicine, zolucatetide, is the first and only direct inhibitor of the β-catenin:TCF interaction, a central node in the Wnt/β-catenin pathway that has eluded drug developers for decades. Zolucatetide is being evaluated in the clinic across multiple Wnt/β-catenin-driven diseases, including desmoid tumors, familial adenomatous polyposis (FAP) and a range of other solid tumor indications. Beyond zolucatetide, Parabilis is advancing additional Helicon-based programs focused on other challenging targets where we believe our medicines could have life-altering impact. For more information, visit www.parabilismed.com or follow us on LinkedIn.
What’s the opportunity?
We are looking for an Associate Director, Financial Planning & Analysis (FP&A) to join our Finance team and partner with leaders across the organization. Reporting to the SVP, Finance, this role will help lead financial planning, forecasting, and reporting across the company, with a focus on the systems, processes, and consolidated roll-ups that underpin the FP&A function. The Associate Director will translate business goals into actionable financial models, scenario analysis, and targeted resource allocation, and will serve as a trusted partner to functional stakeholders, including the Research and Clinical Development teams.
Key Responsibilities:
- Serve as an FP&A business partner to functional leaders across the organization, providing financial insight to support decision-making and resource allocation
- Participate in annual budget, long-range plan, and forecast cycles, ensuring consistency, accuracy, and timeliness of data across functions
- Assist with consolidated financial roll-ups and management reporting, including company-level budget vs. actual and forecast analysis for Finance and leadership
- Help to improve FP&A systems, tools, and models (e.g., planning and forecasting platforms, reporting templates), partnering with Accounting, IT, and other teams as needed
- Assist in the development and standardization of FP&A processes, calendars, and controls to improve efficiency, data integrity, and scalability as the company grows
- Track risks and opportunities to the annual budget and reflect updates in the forecast
- Build financial models and scenario analyses to support strategic planning, portfolio prioritization, and business development activities
- Deliver clear monthly and quarterly analysis and commentary to stakeholders, highlighting key drivers, variances, and actions
- Support cross-functional initiatives and ad hoc analyses as needed
What you’ll need to be successful:
- Bachelor’s degree in Finance, Accounting, or a related field
- Minimum of 6 years of progressive experience in finance, including FP&A, with demonstrated experience participating in planning and forecasting cycles
- Pharmaceutical or biotech FP&A experience required
- Experience supporting R&D or Clinical Development strongly preferred
- Experience with FP&A systems and processes (e.g., Adaptive, Anaplan, Oracle EPM, or similar) and building consolidated reporting
- Strong Excel and financial modeling skills
- Excellent communication skills, with the ability to partner with and influence stakeholders at all levels
- Demonstrated ability to util
Fogpharma kariyer sayfasından